Changes in levels of serum and urinary collagen-related substances in growth hormone deficient children following discontinuation of growth hormone therapy

Endocrine Journal

Volumn 45, Issue SUPPL., 1998, Pages

  Kuno, Tateo ^a   Miyazaki, Sumio ^a  

^a SAGA UNIVERSITY   (Japan)

Author keywords

GH; Hydroxyproline; Prolylhydroxylase; Type III procollagen propeptide; Type IV collagen

Indexed keywords

COLLAGEN TYPE 4; GROWTH HORMONE;

ADOLESCENT; ARTICLE; CHILD; CLINICAL ARTICLE; COLLAGEN METABOLISM; DRUG WITHDRAWAL; FEMALE; GROWTH HORMONE DEFICIENCY; HORMONE ACTION; HORMONE SUBSTITUTION; HUMAN; MALE; OSSIFICATION; OSTEOLYSIS;

EID: 0031864260     PISSN: 09188959     EISSN: None     Source Type: Journal    
DOI: 10.1507/endocrj.45.suppl_s151     Document Type: Article

References (6)

1. Kanzaki S, Hosoda K, Moriwake T, Tanaka H, Kubo T, Inoue M, Higuchi J, Yamaji T, Seino Y (1992) Serum propeptide and intact molecular osteocalcin in normal children and children with GH deficiency: A potential marker of bone growth and response to GH therapy. J Clin Endocrinol Metab 75: 1104-1109.
2. Fujimoto S, Kubo T, Tanaka M, Miura M, Seino Y (1995) Urinary pyridinoline and deoxypyridinoline in healthy children and in children with GH deficiency. J Clin Endocrinol Metab 80: 1922-1928.
3. Kuno T, Tasaki H, Miyazaki S, Horie H (1997) Rapid decrease of urinary pyridinoline excretion in GH deficient children following discontinuation of GH therapy. Acta Paediatr Jpn 39: 18-20.
4. Lindstedt G, Weijkum L, Lundberg PA (1984) Serum procollagen-III as indicator of therapeutic effect in children treated for somatropin deficiency. Clin Chem 30: 1879-1880.
5. Brook CGD, Hindmarsh PC, Smith PJ (1989) The management of short stature. In: Brook CGD (ed) Clinical Paediatric Endocrinology, 2nd ed, Blackwell Scientific Publications, Oxford, 122-123.
6. Murphy LJ, Vrhovsek E, Lazarus L (1983) Identification and characterization of specific growth hormone receptors in cultured human fibroblasts. J Clin Endocrinol Metab 57: 1117-1120.